510(k) K012532
K012532 is an FDA 510(k) premarket notification submitted by Genzyme Corp. for the device "SEPRAGEL SINUS". The FDA issued a decision of Substantially Equivalent on October 30, 2001. The device falls under product code LYA (Splint, Intranasal Septal), a Class I device regulated under 21 CFR 874.4780. Genzyme Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 30, 2001
- Date Received
- August 6, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Splint, Intranasal Septal
- Device Class
- Class I
- Regulation Number
- 874.4780
- Review Panel
- EN
- Submission Type